These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3037028)

  • 1. Characterization of kappa opioid receptors in neurosecretosomes from bovine posterior pituitary.
    Pesce G; Lang MA; Russell JT; Rodbard D; Gainer H
    J Neurochem; 1987 Aug; 49(2):421-7. PubMed ID: 3037028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO; Lang MA; Cruciani RA; Russell JT; Gainer H; Rodbard D
    NIDA Res Monogr; 1986; 75():77-80. PubMed ID: 2893283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla.
    Pesce GO; Cruciani RA; Munson PJ; Rodbard D
    Eur J Pharmacol; 1990 Jul; 182(3):429-39. PubMed ID: 2171945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interaction of opiates to multiple "kappa" binding sites in the guinea-pig lumbo-sacral spinal cord.
    Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
    Life Sci; 1982 Sep 20-27; 31(12-13):1371-5. PubMed ID: 6128659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV; Medzihradsky F
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu and kappa opiate binding sites in the rabbit CNS.
    Meunier JC
    Life Sci; 1982 Sep 20-27; 31(12-13):1327-30. PubMed ID: 6292624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes.
    Demoliou-Mason CD; Barnard EA
    J Neurochem; 1986 Apr; 46(4):1118-28. PubMed ID: 3005504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
    Bunn SJ; Hanley MR; Wilkin GP
    Neurosci Lett; 1985 Apr; 55(3):317-23. PubMed ID: 2989733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of opioid binding sites in murine neuroblastoma.
    Zagon IS; Goodman SR; McLaughlin PJ
    Brain Res; 1988 May; 449(1-2):80-8. PubMed ID: 2899449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin 1-8 binds to opiate kappa receptors in the neurohypophysis.
    Gerstberger R; Barden N
    Neuroendocrinology; 1986; 42(5):376-82. PubMed ID: 2871501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP
    J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.